CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.
about
The genome-wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant responseNational survey and community advisory board development for a bipolar disorder biobank.Effect of Cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors.
P2860
CYP2C19 variation, not citalopram dose nor serum level, is associated with QTc prolongation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
CYP2C19 variation, not citalop ...... ociated with QTc prolongation.
@en
type
label
CYP2C19 variation, not citalop ...... ociated with QTc prolongation.
@en
prefLabel
CYP2C19 variation, not citalop ...... ociated with QTc prolongation.
@en
P2860
P356
P1476
CYP2C19 variation, not citalop ...... sociated with QTc prolongation
@en
P2093
Simon Kung
Yingying Kumar
P2860
P304
P356
10.1177/0269881114543720
P407
P577
2014-08-13T00:00:00Z